corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

All items in the Healthy Skepticism Library

All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.

Page 126 of 206 pages ‹ First  < 124 125 126 127 128 >  Last ›

HSL20024
Morgan JP
Drug Salesman: Hard Sell: The Evolution of a Viagra Salesman
JAMA 2005 July 27;294:(4):496
http://jama.ama-assn.org/content/294/4/496.1.extract

HSL1939
Pollard R.
Drug ad pop-ups ruled out of order
Sydney Morning Herald 2005 Jul 26
http://www.smh.com.au/news/national/drug-ad-popups-ruled-out-of-order/2005/07/25/1122143787346.html

HSL1941
Stafford A.
Study finds drug ads breaching code
The Financial Review ( Australia) 2005 Jul 26

HSL9278
Amin AA, Snow RW.
Brands, costs and registration status of antimalarial drugs in the Kenyan retail sector.
Malar J 2005 Jul 26;4:(1):36
http://www.malariajournal.com/content/4/1/36

HSL16813
Schwitzer G, Mudur G, Henry D, Wilson A, Goozner M, Simbra M, Sweet M, Baverstock KA
What Are the Roles and Responsibilities of the Media in Disseminating Health Information?
PLoS Med 2005 July 26;
http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.0020215

HSL20184
US Pharma seeks voluntary ad code
PMLive.com 2005 July 26
http://www.pmlive.com/pharma_news/us_pharma_seeks_voluntary_ad_code_8159

HSL1944
Adair R, Holmgren L.
Do Free Drug Samples Influence Residents' Prescribing Decisions?
Newswise 2005 Jul 25
http://www.newswise.com/articles/view/513332/

HSL7519
Miles A, Loughlin M.
Continuing the evidence-based health care debate in 2006. The progress and price of EBM
Journal of Evaluation in Clinical Practice 2005 July 25;12:(4):
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2753.2006.00740.x

HSL19509
Cha S
These Gifts are Bad for Our Health.
The Washington Post 2005 July 25
http://www.washingtonpost.com/wp-dyn/content/article/2005/07/22/AR2005072202220.html

HSL1940
Cha S.
These Gifts Are Bad for Our Health
Washington Post 2005 Jul 24

HSL3743
Walley T, Mossialos EA, Mrazek M, de Joncheere CP.
Supply and regulation of medicines.
BMJ 2005 Jul 23;331:(7510):171-2
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3051&uid=16037422&db=pubmed&url=http://bmj.com/cgi/pmidlookup?view=long&pmid=16037422

HSL20046
Gahan L
Controls on GP recreation are too prohibitive
Medical Observer 2005 July 2325

HSL1898
Saul S.
Drug Industry Proposes Limits on Advertising
New York Times 2005 Jul 22
http://www.nytimes.com/2005/07/22/business/media/22pharma.html

HSL1938
Allen L.
Medicine ads 'breach code'
The Financial Review ( Australia) 2005 Jul 22

HSL1945
Baum Hedlund.
Federal Judge Rejects Pfizer’s Efforts to Dismiss Zoloft-Suicide Lawsuit
2005 Jul 22
http://www.baumhedlundlaw.com/media/zoloft/Woody/WitczakPreemptionWin.htm

HSL20075
Fleming K
Study finds potential software ad breaches
Medical Observer 2005 July 228

HSL7457
Berenson A.
In Training Video, Merck Said Vioxx Did Not Increase Risk of Heart Attack
New York Times 2005 Jul 21Business
http://www.nytimes.com/2005/07/21/business/21vioxx.html?ex=1279598400&en=408e6e6a800498b2&ei=5088&partner=rssnyt&emc=rss

HSL1829
Center for public integrity investigates biotech & pharmaceutical industries
Biomedical Market Newsletter 2005 Jul 20
http://sacserv.com/links.jsp?linkid=21395&subid=1262876&custid=76&campid=142643&type=0

HSL1832
Coultan M.
Bitter pill poppers cut costs
Sydney Morning Herald 2005 Jul 20
http://www.smh.com.au/news/national/bitter-pill-poppers-cut-costs/2005/07/19/1121538975659.html

HSL1942
AMA Poll Shows Patients Are Concerned About the Privacy and Security of Their Medical Records
AMA ( Australian Medical Association ) 2005 Jul 20
http://www.ama.com.au/web.nsf/doc/WEEN-6EG7LY

HSL2132
Ford ES, Ajani UA, Mokdad AH.
Brief communication: The prevalence of high intake of vitamin E from the use of supplements among U.S. adults.
Ann Intern Med. 2005 Jul 19;143:(2):116-20
http://www.annals.org/cgi/content/full/143/2/116

HSL1830
Blagojevich R.
Governor Blagojevich and partners in I-SaveRx drug importation program announce major supply expansion
Illinois Government News Network 2005 Jul 18
http://www.illinois.gov/PressReleases/ShowPressRelease.cfm?SubjectID=3&RecNum=4164

HSL1937
Harvey KJ, Vitry AI., Aroni R, Ballenden N, Faggotter R.
Pharmaceutical advertisements in prescribing software: an analysis
MJA 2005 Jul 18;183:(2):75-79
http://www.mja.com.au/public/issues/183_02_180705/har10263_fm.html

HSL1957
Croasdale M.
Drug firms to fund residency slots in dermatology pilot program
American Medical Association ( AMA News) 2005 Jul 18
http://www.amednews.com/2005/prl20718

HSL2122
Ruff TA, Haikal-Mukhtar H.
Doctors, drugs, information and ethics: a never-ending story.
Med J Aust 2005 Jul 18;183:(2):73-4
http://www.mja.com.au/public/issues/183_02_180705/ruf10450_fm.html

HSL8069
Miller L.
Dr. Pitchman Sells More Drugs
PR Watch 2005 Jul 18
http://www.prwatch.org/node/3854

HSL1927
Choi C.Q.
How mtDNA mutations cause aging
The Scientist 2005 Jul 15
http://www.the-scientist.com/news/20050715/02

HSL3756
Hensley S, Martinez B.
To Sell Their Drugs, Companies Increasingly Rely on Doctors For $750 and Up, Physicians Tell Peers About Products.
Wall Street Journal 2005 Jul 15A1
http://www.scribd.com/doc/19059620/090708-S-v-Johnstone-A19-Iatrogenic-Medical-Genocide-Industrial-Complex

HSL4946
Sundstrom L, Morrison B 3rd, Bradley M, Pringle A.
Organotypic cultures as tools for functional screening in the CNS.
Drug Discov Today 2005 Jul 15;10:(14):993-1000
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T64-4GMB0F0-D&_coverDate=07%2F15%2F2005&_alid=406423296&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=5020&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=c03da4a6b488ecbf4688958874e08133

HSL20076
Fleming K
Relief from GP software
Medical Observer 2005 July 157

HSL1833
Follow-Up Studies Often Contradict Earlier Research on Same Treatments
Medical News Today 2005 Jul 14
http://bmj.bmjjournals.com/cgi/content/full/331/7509/165?ehom

HSL20073
Limprecht E
Bateman pledges to cut 'annoying' ad distractions
Australian Doctor 2005 July 13
http://www.australiandoctor.com.au/news/latest-news/bateman-pledges-to-cut---8216;annoying--8217;-ad-d

HSL16891
Hoffman JR, Brody H
The Boy Who Cried Unicorn: A Parable
Annals of Emercency Medicine 2005 July 7;46:(1):93
http://www.annemergmed.com/article/S0196-0644(04)01681-6/fulltext

HSL1705
Elliott C.
Should journals publish industry-funded bioethics articles?
The Lancet 2005 Jul 6;366:
http://www.thelancet.com/journals/lancet/article/PIIS0140673605667943/fulltext

HSL1694
Saul S.
Senate Leader Calls for Limits on Drug Ads
New York Times 2005 Jul 21

HSL1697
Silberner J.
Drug Companies Rethink Ad Strategies
All Things Considered (NPR Radio Program) 2005 Jul 2
http://www.npr.org/templates/story/story.php?storyId=4727781

HSL1693
Menzies B
Statement regarding FDA antidepressant advisory for adults and suicidality
Baum Hedlund ( Los Angeles, California) 2005 Jul 1
http://www.baumhedlundlaw.com/media/ssri/Adult%20Warnings/FDA-Adult-Suicide-Warning.htm

HSL1698
Burcher S.
NIH-Sponsored AIDS Drugs Tests on Mothers and Babies
Institute of Science in Society 2005 Jul 1
http://www.i-sis.org.uk/NSADTMB.php

HSL1704
Ismail M.
Exporting Prices - Drug makers' trade group makes the industry's priorities U.S. trade policy
The Center for Public Integrity 2005 Jul 1
http://www.publicintegrity.org/lobby/report.aspx?aid=718&sid=200

HSL3595
Croll TP, Swanson BZ Jr19th century dentistry.
Advertising trade cards.
J Hist Dent 2005 Jul 01;53:(2):62

HSL3715
Owens J.
Pharma allowed to make own genetics.
Nat Rev Drug Discov 2005 Jul 01;4:(7):530

HSL3717
Incentive to be inventive.
Nat Rev Drug Discov 2005 Jul 01;4:(7):523

HSL3757
A gift to pharma?
Nat Med 2005 Jul 01;11:(7):693
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3094&uid=16015340&db=pubmed&url=http://dx.doi.org/10.1038/nm0705-693

HSL3761
Ross DE.
Methodological concerns in a trial of ziprasidone and olanzapine.
Am J Psychiatry 2005 Jul 01;162:(7):1391
http://ajp.psychiatryonline.org/cgi/content/full/162/7/1391-a

HSL3763
Roizen MF.
What's wrong with this label?
Anesthesiology 2005 Jul 01;103:(1):4-5
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0003-3022&volume=103&issue=1&spage=4

HSL3773
Clauson KA, Santamarina ML, Buettner CM, Cauffield JS.
Evaluation of presence of aspirin-related warnings with willow bark.
Ann Pharmacother 2005 Jul-Aug 01;39:(7-8):1234-7
http://www.theannals.com/cgi/content/full/39/7/1234

HSL3780
Knapp P, Raynor DK, Jebar AH, Price SJ.
Interpretation of medication pictograms by adults in the UK.
Ann Pharmacother 2005 Jul-Aug 01;39:(7-8):1227-33
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3051&uid=15897266&db=pubmed&url=http://www.theannals.com/cgi/pmidlookup?view=long&pmid=15897266

HSL4586
Chimonas S, Rothman DJ.
New federal guidelines for physician-pharmaceutical industry relations: the politics of policy formation.
Health Aff (Millwood) 2005 Jul-Aug;24:(4):949-60
http://www.healthaffairs.org/

HSL4595
Hale VG, Woo K, Lipton HL.
Oxymoron no more: the potential of nonprofit drug companies to deliver on the promise of medicines for the developing world.
Health Aff (Millwood) 2005 Jul-Aug;24:(4):1057-63
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3051&uid=16012146&db=PubMed&url=http://content.healthaffairs.org/cgi/pmidlookup?view=long&pmid=16012146

HSL5130
Senior K.
Neglected diseases: getting less neglected?
Drug Discov Today 2005 Jul 1;10:(13):878
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3048&uid=15993802&db=PubMed&url=http://linkinghub.elsevier.com/retrieve/pii/S1359-6446(05)03519-1

HSL5161
Ellis CN, Pillitteri JL, Kyle TK, Ertischek MD, Burton SL, Shiffman S.
Consumers appropriately self-treat based on labeling for over-the-counter hydrocortisone.
J Am Acad Dermatol 2005 Jul 01;53:(1):41-51
http://linkinghub.elsevier.com/retrieve/pii/S0190962205004408

HSL5228
Wager E, Jacobs A.
Response to 'the corporate coauthor'.
J Gen Intern Med 2005 Jul 01;20:(7):672
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1525-1497.2005.051181.x

HSL5349
Miller RA, Gardner RM, Johnson KB, Hripcsak G.
Clinical decision support and electronic prescribing systems: a time for responsible thought and action.
J Am Med Inform Assoc 2005 Jul-Aug 01;12:(4):403-9
http://www.jamia.org/cgi/content/full/12/4/403

HSL5836
Cohen D.
Bold suggestion by Smith.
PLoS Med 2005 Jul 01;2:(7):e226
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pubmed&pubmedid=16033320

HSL5837
Sheldon T.
Focus on the funding and production of evidence rather than its publication.
PLoS Med 2005 Jul 01;2:(7):e222
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pubmed&pubmedid=16033316

HSL5838
Marcovitch H.
Little fish are less likely to take the bait.
PLoS Med 2005 Jul 01;2:(7):e221
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pubmed&pubmedid=16033315

HSL5839
Sackett D.
Might banning trial publication do more harm than good?
PLoS Med 2005 Jul 01;2:(7):e220
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0020220

HSL5840
Senn S.
Bitter pills and puffed trials.
PLoS Med 2005 Jul 01;2:(7):e219
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pubmed&pubmedid=16033313

HSL5841
Frighi V.
Medical journals, academia, and industry-sponsored clinical trials.
PLoS Med 2005 Jul 01;2:(7):e218
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pubmed&pubmedid=16033312

HSL5843
Why PLoS sponsored a roundtable of medical whistleblowers.
PLoS Med 2005 Jul 01;2:(7):e208
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pubmed&pubmedid=15913415

HSL6236
Bergk V, Haefeli WE, Gasse C, Brenner H, Martin-Facklam M.
Information deficits in the summary of product characteristics preclude an optimal management of drug interactions: a comparison with evidence from the literature.
Eur J Clin Pharmacol 2005 Jul 01;61:(5-6):327-35
http://www.springerlink.com/content/l02745780316mr4t/

HSL20038
Fleming K
'Gift' pens and notepads labelled unethical
Medical Observer 2005 July 111

HSL2073
Nuwaha F, Okware J, Ndyomugyenyi R.
Predictors of compliance with community-directed ivermectin treatment in Uganda: quantitative results.
Trop Med Int Health 2005 Jul;10:(7):659-67
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-3156.2005.01436.x?cookieSet=1

HSL2118
Cummings KC, Rosenberg J, Vugia DJ.
Beliefs about appropriate antibacterial therapy, California.
Emerg Infect Dis 2005 Jul;11:(7):1138-41
http://www.cdc.gov/ncidod/EID/vol11no07/05-0112.htm

HSL2125
Richards T.
Global university course launched on health advocacy
Jul 2005 Jul;331:256
http://bmj.bmjjournals.com/cgi/content/extract/331/7511/256-a

HSL2126
Roehr B.
Report argues US should not pay more than rest of world to fight HIV/AIDS
BMJ 2005 Jul;331:256
http://bmj.bmjjournals.com/cgi/content/extract/331/7511/256-b

HSL2127
Burton B.
US governor plans to import cheaper drugs from Australia and New Zealand
BMJ 2005 Jul;331:256.
http://bmj.bmjjournals.com/cgi/content/extract/331/7511/256-c?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&author1=burton+b&andorexactfulltext=and&searchid=1124344014667_19124&stored_search=&FIRSTINDEX=0&sortspec=relevance&resourcetype=1

HSL2129
Expression of concern
BMJ 2005 Jul;331:266
http://bmj.bmjjournals.com/cgi/content/full/331/7511/266

HSL2273
Flordellis CS.
The emergence of a new paradigm of pharmacogenomics.
Pharmacogenomics 2005 Jul;6:(5):515-26
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16014001&query_hl=5

HSL2274
Gleason PP, Williams C, Hrdy S, Hartwig SC, Lassen D.
Medical and pharmacy expenditures after implementation of a cyclooxygenase-2 inhibitor prior authorization program.
Pharmacotherapy 2005 Jul;25:(7):924-34
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&DB=pubmed

HSL3492
Lenzer J .
What can we learn from medical whistleblowers?
PLoS Med 2005 Jul;2:(7):e209
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0020209

HSL3716
Frantz S.
Big companies helped by safe harbour ruling.
Nat Rev Drug Discov 2005 Jul 01;4:(7):525-6

HSL3727
Berndt ER, Gottschalk AH, Philipson TJ, Strobeck MW.
Industry funding of the FDA: effects of PDUFA on approval times and withdrawal rates.
Nat Rev Drug Discov 2005 Jul;4:(7):545-54
http://www.nature.com/nrd/journal/v4/n7/abs/nrd1774_fs.html;jsessionid=6DC8F63114D6CEAB8D0F8190F4F3072B

HSL3742
Taylor JP, Evers S, McKenna M.
Determinants of healthy eating in children and youth.
Can J Public Health 2005 Jul-Aug;96:

HSL4803
Damodaran RT.
Brand confusion causes allergic dermatitis.
J Postgrad Med 2005 Jul-Sep;51:(3):242
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3153&uid=16333208&db=PubMed&url=http://www.jpgmonline.com/article.asp?issn=0022-3859;year=2005;volume=51;issue=3;spage=242;epage=242;aulast=Damodaran

HSL4806
Wertheimer AI, Santella TM.
Counterfeit drugs: defining the problem and finding solutions.
Expert Opin Drug Saf 2005 Jul;4:(4):619-22
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3204&uid=16011440&db=PubMed&url=http://www.ashley-pub.com/doi/abs/10.1517/14740338.4.4.619

HSL4830
Althof SE, Goldstein I, Becher E, Giraldi A, Vardi Y, Dennerstein L, Marson L, Brotto L, Schreiner-Engel P, Wallen K, Clayton A, Altman A, Kingsberg S, Shabsigh R; Board of Directors of the International Society for the Study of Women's Sexual Health.
The other side: failure in fair and balanced reporting.
J Sex Med 2005 Jul;2:(4):583-4

HSL5374
Rosenbloom ST, Geissbuhler AJ, Dupont WD, Giuse DA, Talbert DA, Tierney WM, Plummer WD, Stead WW, Miller RA.
Effect of CPOE user interface design on user-initiated access to educational and patient information during clinical care.
J Am Med Inform Assoc 2005 Jul-Aug;12:(4):458-73
http://www.jamia.org/cgi/content/full/12/4/458

HSL7407
Napoli M.
Why Do We Need A Publicly Funded, Publicly Accessible Database Of Clinical Trials?
Center for Medical Consumers 2005 Jul
http://www.medicalconsumers.org/pages/StopDrugCompaniesfromHidingNegativeResults.html

HSL8798
Carpenter D.
A proposal for financing postmarketing drug safety studies by augmenting FDA user fees.
Health Aff (Millwood) 2005 Jul-Dec;Suppl:
http://content.healthaffairs.org/cgi/reprint/hlthaff.w5.469v1

HSL9361
Bailey PG.
New ethical code reflects expectations for industry behavior.
J Am Coll Radiol 2005 Jul;2:(7):622-5
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17411889&query_hl=7&itool=pubmed_docsum

HSL1702
Kelleher S.
Suddenly Sick Part 6 ( Female Sexual Dysfunction)
The Seattle Times 2005 Jun 30

HSL20185
Limprecht E
Web watchdog bites media medical coverage
Australian Doctor 2005 Jun 304
http://www.australiandoctor.com.au/news/latest-news/web-watchdog-bites-media-medical-coverage

HSL1701
Kelleher S.
Suddenly Sick Part 5 ( Deep Vein Thrombosis )
The Seattle Times 2005 Jun 29

HSL1919
Safety and Efficacy of SSRIs in Children and Adolescents
American Medical Association 2005 Jun 29
http://www.ama-assn.org/ama/pub/category/print/15186.html

HSL1700
Kelleher S.
Suddenly Sick Part 4 ( Osteoporosis )
The Seattle Times 2005 Jun 28

HSL1659
Mansfield PR.
Response to Pfizer
BMJ 2005 Jun 27;
http://bmj.bmjjournals.com/cgi/eletters/328/7444/879#110681

HSL1699
Kelleher S.
Suddenly Sick Part 3 ( Obesity)
The Seattle Times 2005 Jun 27

HSL1644
Kelleher S.
Suddenly Sick Part 1 (Introduction)
The Seattle Times 2005 Jun 26

HSL1648
Griffith D.
Health Group's Funding Faulted
The Sacramento Bee 2005 Jun 26
http://www.sacbee.com/content/news/projects/drugs/story/13132395p-13976434c.html

HSL1703
Wilson D.
Suddenly Sick Part 2 (Hypertension)
The Seattle Times 2005 Jun 26

HSL1649
Lewis L.
AstraZenica faces threat of charges in Japan
Times Online 2005 Jun 24
http://business.timesonline.co.uk/article/0,,9068-1667153,00.html

HSL5846
Toop L, Richards D, Dowell T.
Response to Maubach and Hoek's paper on GP attitudes to DTCA
N Z Med J. 2005 Jun 24;118:(1217):U1543

HSL1621
Waxman H.
The Lessons of Vioxx - Drug Safety and Sales
The New England Journal of Medicine 2005 Jun 23; 352:(25):2576-2578

HSL1645
Avorn J.
Torcetrapib and atorvastatin--should marketing drive the research agenda?
N Engl J Med 2005 Jun 23;352:(25):2573-6
http://content.nejm.org/cgi/content/extract/352/25/2573

HSL1696
Agovino T.
Merck Tried to Alter Vioxx in 2000
Associated Press 2005 Jun 23

HSL13059
Antidepressants barely better than placebos
New Scientist 2005 Jun 23
http://www.newscientist.com/channel/health/mental-health/mg18725096.000-antidepressants-barely-better-than-placebos.html

HSL1834
Daemmrich A., Bowden M.
A RISING DRUG INDUSTRY
Chemical and Engineering News 2005 Jun 20
http://pubs.acs.org/cen/coverstory/83/8325/index.html

HSL1831
Pharma Reformulates Marketing Plans
Eye For Pharma 2005 Jun 19
http://www.eyeforpharma.com/print.asp?news=46904

HSL1634
Metherell M.
Lung cancer drugs will cost more
The Sydney Morning Herald 2005 Jun 17;
http://www.smh.com.au/news/National/Lung-cancer-drugs-will-cost-more/2005/06/16/1118869048092.html

Page 126 of 206 pages ‹ First  < 124 125 126 127 128 >  Last ›

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.